article thumbnail

The European Market Access Lag: 2021–2024

Pharmaceutical Technology

For example, Recordati’s Cystadane (betaine) was centrally approved in 2007 but did not see its first reimbursement in Poland until 2023. In Romania, Novartis’s Atriance (nelarabine) was also centrally approved in 2007 but did not receive its first reimbursement in Romania until 2021.

article thumbnail

Radical Transparency or Radical Redundancy? FDA Publishes 200+ Complete Response Letters, Most of Which Are Already Public

The FDA Law Blog

Greater transparency into our decisions will help align expectations and foster better communication among stakeholders.” If a drug is approved, section 916 of the Food and Drug Administration Amendments Act of 2007 (FDAAA) (codified at 21 U.S.C. §

FDA 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

OTCAS short answer essay questions

Blog: Ask a Student Pharmacist

Describe a situation where you used your language and communication skills to engage more effectively with another person or group that was different from you. How did you approach it, and what was the outcome? Rate your level of fluency in a second language (including ASL). Consider this information as you respond to the following questions.

article thumbnail

Hank Green on his ‘P **g Out Cancer’ comedy special, ulcerative colitis, and the jokes that got cut

STAT

The counter resets often — the multi-hyphenate internet educator and science communicator rose to prominence with his 2007 YouTube project Vlogbrothers , which he founded with his brother, the novelist-turned- tuberculosis-fighter John Green. Free, educational YouTube channels Crash Course , SciShow , and Study Hall followed.

article thumbnail

Patient centricity 101: How to create content that REALLY communicates

pharmaphorum

According to the European Commission and NIHR Clinical Research Network, between 2007 and 2011, delays for launching clinical trials rose by 90%. And with approximately one third of the clinical trial timeline spent in patient recruitment, delays in launching clinical trials will increase costs and drain resources.

article thumbnail

Top email calamities to avoid … and how to make an impact instead

pharmaphorum

Oliver Stohlmann’s Corporate Survival Hacks series draws on his experiences of working in local, regional and global life science communications to offer some little tips for enjoying a big business career. In this column he addresses the appropriate use of email and how to avoid nightmares in electronic communication.

article thumbnail

Creative agency woolley pau regains independence after buyout

pharmaphorum

Shorthose, Christian Dawson and Dean Woolley bought out the agency, which was had previously been acquired by healthcare communications company gyro in 2007 and then in 2016 by digital marketing company Dentsu Aegis Network. Ed Shorthose, managing director, said the move “felt right on every level”.